Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) EPS (Weighted Average and Diluted) (2024 - 2025)

Historic EPS (Weighted Average and Diluted) for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to -$0.33.

  • Beta Bionics' EPS (Weighted Average and Diluted) rose 7739.73% to -$0.33 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.39, marking a year-over-year increase of 5.62%. This contributed to the annual value of -$6.5 for FY2024, which is 2183.94% up from last year.
  • Beta Bionics' EPS (Weighted Average and Diluted) amounted to -$0.33 in Q3 2025, which was up 7739.73% from -$0.39 recorded in Q2 2025.
  • Over the past 5 years, Beta Bionics' EPS (Weighted Average and Diluted) peaked at -$0.33 during Q3 2025, and registered a low of -$2.37 during Q2 2024.